NDC 43386-762-01 - ZOLPIDEM TARTRATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43386-762
- Requested NDC
- 43386-762-01
- Package NDCs from labels
- 43386-762-01, 43386-762-30
- Manufacturer
- Lupin Pharmaceuticals,Inc. | Novel Laboratories, Inc.
- Effective date
- 2020-11-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ZOLPIDEM TARTRATE - Lupin Pharmaceuticals,Inc. | Novel Laboratories, Inc. | Lupin Pharmaceuticals,Inc. | Novel Laboratories, Inc. | 2020-11-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43386-762-01 | ZOLPIDEM TARTRATE | 1 in 1 BLISTER PACK | TABLET | 1 | 6 | |
| 43386-762-01 | ZOLPIDEM TARTRATE | 1 in 1 POUCH | TABLET | 1 | 6 | |
| 43386-762-30 | ZOLPIDEM TARTRATE | 30 in 1 CARTON | TABLET | 30 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43386-762-01 | EA - Each | 43386-762 | 4be89bd4-4a1c-45bb-8486-7834ddbbe15f | 1 | 2019-02-13 |
| 43386-762-30 | EA - Each | 43386-762 | ccf4d3fa-09a8-4f9c-8fbe-7c77ebbcaf5b | 1 | 2016-04-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZOLPIDEM TARTRATE | ZOLPIDEM TARTRATE | Preferred Pharmaceuticals Inc. | 76ff87e4-3aa2-439d-8436-d9e6affb33c8 | 2026-11-05 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | PD-Rx Pharmaceuticals, Inc. | 38c838a4-9943-445a-8e80-e823d56eeaa5 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| Stomachin Antacid | MAGNESIUM CARBONATE AND SODIUM BICARBONATE | Chang Kuo Chou Pharmaceutical Co., Ltd. | 60fa0650-8785-4cb3-8f88-1a437296252f | 2026-11-02 | Warnings | 8MDF5V39QO |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2026-11-02 | Warnings, Adverse reactions | 3OWL53L36A |
| Arm and Hammer Baking Soda | SODIUM BICARBONATE | Church & Dwight Co., Inc. | 643fe204-4a7b-00e4-e053-2a91aa0aef06 | 2026-10-28 | Warnings | 8MDF5V39QO |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | PD-Rx Pharmaceuticals, Inc. | fda413e7-b1ae-312a-e053-6394a90ab2c6 | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| Zegerid OTC | OMEPRAOLE, SODIUM BICARBONATE | Riley Consumer Care LLC | 8d00c19a-d86b-4a2f-8791-b320ad3ca781 | 2026-10-26 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate 10 gr | SODIUM BICARBONATE | GRAXCELL PHARMACEUTICAL, LLC | 897dbb09-fb47-4e03-8cae-bf76d48a7a03 | 2026-10-26 | Warnings | 8MDF5V39QO |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | Umedica Laboratories USA Inc. | b49f6c18-e155-4728-a79a-9354e8c3c8f4 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | TORRENT PHARMACEUTICALS LIMITED | 9025a6f7-5501-4aba-875e-222ef39848c0 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | WY6W63843K |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Rugby Laboratories | e73b5871-4a87-4473-ab00-5e5395be017d | 2026-10-16 | Warnings | 8MDF5V39QO |
| After Bite Advanced | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 223d1de8-7940-bbdc-e063-6294a90a51d8 | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 1484a825-40c6-a9c9-e063-6294a90a9ca4 | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-300 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | c3cd7f0f-8d70-23af-e053-2a95a90a569b | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 28152c9f-b15c-3707-e063-6394a90a70e9 | 2026-10-16 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Sun Pharmaceutical Industries, Inc. | 5ae65432-04a1-4b6b-8536-2535064fc782 | 2026-10-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| Good Sense Omeprazole and Sodium Bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | L. Perrigo Company | bcf32242-de17-4da1-b707-4ce26262eb78 | 2026-10-14 | Warnings | 8MDF5V39QO |
| Sal De Uvas Picot | CITRIC ACID MONOHYDRATE, SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | ff6ac79d-564d-4abf-83c7-b01751249c7f | 2026-10-09 | Warnings | 8MDF5V39QO |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.